Caricamento...
Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches
A better understanding of the biology of renal cell carcinoma (RCC) has significantly changed the treatment paradigm of the disease. Several novel VEGF and TORC inhibitors have bee recently FDA-approved. Unfortunately, the vast majority of clinical trials conducted today have been aimed to include p...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4165483/ https://ncbi.nlm.nih.gov/pubmed/23972715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2013.05.009 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|